Susquehanna International Group’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$769K Buy
25,500
+500
+2% +$16.2K ﹤0.01% 8579
2025
Q4
$868K Sell
25,000
-73,000
-74% -$2.58M ﹤0.01% 7502
2025
Q3
$3.56M Sell
98,000
-400
-0.4% -$13.6K ﹤0.01% 4661
2025
Q2
$3.09M Sell
98,400
-21,000
-18% -$652K ﹤0.01% 4903
2025
Q1
$3.54M Buy
119,400
+111,800
+1,471% +$3.35M ﹤0.01% 4323
2024
Q4
$224K Sell
7,600
-62,200
-89% -$1.97M ﹤0.01% 10466
2024
Q3
$2.17M Sell
69,800
-22,000
-24% -$800K ﹤0.01% 5106
2024
Q2
$3.11M Sell
91,800
-119,600
-57% -$6.1M ﹤0.01% 4237
2024
Q1
$13.7M Buy
211,400
+21,100
+11% +$1.45M ﹤0.01% 2204
2023
Q4
$13M Buy
190,300
+76,500
+67% +$3.98M ﹤0.01% 2307
2023
Q3
$5.91M Sell
113,800
-75,600
-40% -$4.47M ﹤0.01% 3265
2023
Q2
$11.4M Buy
189,400
+7,600
+4% +$434K ﹤0.01% 2353
2023
Q1
$8.99M Buy
181,800
+95,800
+111% +$5.39M ﹤0.01% 2599
2022
Q4
$4.91M Buy
86,000
+62,400
+264% +$3.51M ﹤0.01% 3268
2022
Q3
$1.11M Sell
23,600
-9,700
-29% -$462K ﹤0.01% 6371
2022
Q2
$1.24M Buy
+33,300
New +$1.08M ﹤0.01% 5989

Other funds holding IMCR

Susquehanna International Group's IMCR Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunocore (IMCR) stake by 75% in Q1 2026, selling an estimated $859K and leaving 8,622 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #11178.

Susquehanna International Group first reported a position in IMCR in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.49M in Q3 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Susquehanna International Group held 8,622 shares of Immunocore worth $260K as of Q1 2026.
  • Susquehanna International Group sold 26,566 Immunocore shares in Q1 2026, an estimated $859K.
  • Immunocore made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11178 holding.
  • Susquehanna International Group first reported a position in Immunocore in Q2 2022 and has held it in 10 quarters since.
  • Susquehanna International Group's Immunocore position peaked at $3.49M in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.